Medicure appoints Henley as CFO

Medicure, a cardiovascular-focused biopharmaceutical company, has appointed Dwayne Henley as its new chief financial officer.

Henley is a chartered accountant with nearly 10 years of senior management and finance experience in both public and private companies. Henley will replace Derek Reimer, who has resigned to pursue other interests, according to Winnipeg, Manitoba-based company.

Henley joins Medicure from a private investment and management company where he held the position of vice president of finance, Medicure said. Prior to that Henley's was vice president of finance for a privately owned transportation company operating throughout North America.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.